Showing results (1-10 of 172) with videos related to

Sort By:
Pageof 18
Transfusion|July 23, 2020
Therapeutic plasma exchange taper does not decrease exacerbations in immune thrombotic thrombocytopenic purpura patientsJay S Raval, Marshall A Mazepa, Marian A Rollins-Raval, et al.
American Journal of Therapeutics|January 3, 2018
Bortezomib for Refractory Immune-Mediated Thrombocytopenia PurpuraJoan D Beckman, Marian A Rollins-Raval, Jay S Raval, et al.
Journal of Pathology Informatics|October 2, 2012
Experience with CellaVision DM96 for peripheral blood differentials in a large multi-center academic hospital systemMarian A Rollins-Raval, Jay S Raval, Lydia Contis
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|September 5, 2018
Predictive Value of Schistocytes in Recurrence of Acquired Thrombotic Thrombocytopenic Purpura With Severe ADAMTS13 Deficiency at Discontinuation of Daily Therapeutic Plasma ExchangeAlexis R Peedin, Yara A Park, Marshall A Mazepa, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|September 9, 2014
Cardiac injury is a common postmortem finding in thrombotic thrombocytopenic purpura patients: is empiric cardiac monitoring and protection needed?Larry Nichols, Aaron Berg, Marian A Rollins-Raval, et al.
Journal of Clinical Apheresis|November 8, 2019
Heparin-induced thrombocytopenia associated with collection of hematopoietic progenitor cells by apheresisJay S Raval, Yara A Park, Irina Perjar, et al.
Journal of Clinical Apheresis|October 15, 2013
Seasonal distribution of severe ADAMTS13 deficient idiopathic thrombotic thrombocytopenic purpuraJay S Raval, Sarah K Harm, Marian A Rollins-Raval, et al.
Pageof 18